Marilena Vrana/LinkedIn
Oct 5, 2025, 11:50
Marilena Vrana: Europe’s Plasma Supply Chain is at a Critical Juncture, and Current Policies are not Equipped to Fix it
Marilena Vrana, Vice President at the Plasma Protein Therapeutics Association (PPTA) Europe, shared a post on LinkedIn:
“Europe’s plasma supply chain is at a critical juncture, and current policies are not equipped to fix it.
In my latest opinion piece The Brussels Times, I break down why plasma-derived medicines require a holistic policy approach – especially as the Critical Medicines Act takes shape.
- Europe’s dependence on US plasma
- Why PDMPs don’t fit policies designed to tackle supply chains of chemically synthesized pharmaceuticals
- The pitfalls of “one-size-fits-all” approach
- The importance of collaboration
If we, Europeans, aim to achieve strategic autonomy and security of medicines supply, our policies must be grounded in reality.
International Plasma Awareness Week, which starts on October 6th, offers the perfect moment to reset Europe’s approach.”
Read more here.
Stay updated with Hemostasis Today.
-
Feb 23, 2026, 18:13Fight4Hematology Supports Research and Empowers the Next Generation – ASH
-
Feb 23, 2026, 17:59Wolfgang Miesbach: Real-World Evidence of Emicizumab on Joint Outcomes in Hemophilia A
-
Feb 23, 2026, 17:56Shiny K Kajal: The Transfusion Reaction We Often Miss
-
Feb 23, 2026, 17:53Radheshyam Meher: Contributing to the Transfusion Evidence Round-Up for International Childhood Cancer Day 2026
-
Feb 23, 2026, 17:46Mahesan Subramaniam: The Physiological Impact of Anger on Immunity
-
Feb 23, 2026, 17:42Bryan Fry: First Evidence That Bothrops atrox Venom Directly Activates Human Factor VII
-
Feb 23, 2026, 17:34Bastu Odoka: Why Blood Should NOT be Left at the Bedside to ‘Warm’
-
Feb 23, 2026, 17:28Henry Burkitt: Patients Are Challenging How the Medicines Policy System Works in England
-
Feb 23, 2026, 16:50Mutaz Al‑Sabah: Interesting Webinar on FH in Women is Now Available to Watch